Scientific Letters
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Anti-mullerian hormone evaluates ovarian function in patients with non-transfusion-dependent thalassemia
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: November 1, 2024
Accepted: December 2, 2024
Accepted: December 2, 2024
1266
Views
1062
Downloads
128
HTML
Authors
Objective:
This study analyzed anti-mullerian hormone (AMH) levels in patients with non-transfusion-dependent thalassemia (NTDT) to evaluate their ovarian function.
Downloads
Download data is not yet available.
Citations
How to Cite
“Anti-mullerian hormone evaluates ovarian function in patients with non-transfusion-dependent thalassemia” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025007. doi:10.4084/MJHID.2025.007.
Copyright (c) 2024 Yan Li, Kun Yang, Yali Zhou, Shiwu Cheng
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
